BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1697154)

  • 1. [Combination of chemotherapy and immunotherapy in man--review].
    Ohnuma T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1428-36. PubMed ID: 1697154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of combination biotherapy studies: future goals and challenges.
    Gilewski TA; Golomb HM
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bases on timing of combined modality of chemotherapy and immunotherapy].
    Ogura T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1414-20. PubMed ID: 1697153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumoricidal biological response modifiers (BRM)].
    Niitsu Y; Kohgo Y; Watanabe N
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1407-13. PubMed ID: 1697152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy of melanoma with cytokines and lymphocytes.
    Bear HD; Hamad GG; Kostuchenko PJ
    Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Urba WJ
    Cancer Chemother Biol Response Modif; 1992; 13():205-29. PubMed ID: 1382527
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.
    Bukowski RM
    Semin Oncol; 2000 Apr; 27(2):204-12. PubMed ID: 10768599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of clinical trials with biological response modifiers.
    Herberman RB
    Cancer Treat Rep; 1985 Oct; 69(10):1161-4. PubMed ID: 2412692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical management of malignant thymoma.
    Hejna M; Haberl I; Raderer M
    Cancer; 1999 May; 85(9):1871-84. PubMed ID: 10223225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C
    Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapy by biological response modifiers.
    Herberman RB
    Clin Physiol Biochem; 1987; 5(3-4):238-48. PubMed ID: 2441918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
    Fuggetta MP; D'Onofrio C; Bonmassar E
    Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer].
    Wirth M
    Urologe A; 1991 Mar; 30(2):77-80. PubMed ID: 1711729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced colorectal cancer.
    Abbruzzese JL; Levin B
    Hematol Oncol Clin North Am; 1989 Mar; 3(1):135-53. PubMed ID: 2465291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical symptoms of combination biotherapy: a quality-of-life issue.
    Brophy LR; Sharp EJ
    Oncol Nurs Forum; 1991; 18(1 Suppl):25-30. PubMed ID: 1997974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.